Pulmonx Corporation
NASDAQ:LUNG
6.88 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 20.387 | 20.783 | 18.854 | 19.278 | 17.668 | 17.194 | 14.535 | 15.425 | 13.502 | 13.95 | 10.785 | 13.708 | 13.261 | 12.203 | 9.244 | 9.83 | 10.612 | 3.673 | 8.618 | 10.347 | 9.104 | 7.366 | 6.572 |
| Cost of Revenue
| 5.361 | 5.476 | 4.876 | 4.978 | 4.639 | 4.46 | 3.946 | 4.241 | 3.35 | 3.532 | 2.674 | 3.457 | 3.522 | 3.174 | 2.633 | 2.752 | 3.15 | 2.661 | 2.968 | 3.01 | 2.697 | 2.413 | 2.237 |
| Gross Profit
| 15.026 | 15.307 | 13.978 | 14.3 | 13.029 | 12.734 | 10.589 | 11.184 | 10.152 | 10.418 | 8.111 | 10.251 | 9.739 | 9.029 | 6.611 | 7.078 | 7.462 | 1.012 | 5.65 | 7.337 | 6.407 | 4.953 | 4.335 |
| Gross Profit Ratio
| 0.737 | 0.737 | 0.741 | 0.742 | 0.737 | 0.741 | 0.729 | 0.725 | 0.752 | 0.747 | 0.752 | 0.748 | 0.734 | 0.74 | 0.715 | 0.72 | 0.703 | 0.276 | 0.656 | 0.709 | 0.704 | 0.672 | 0.66 |
| Reseach & Development Expenses
| 3.744 | 3.898 | 4.21 | 3.896 | 4.22 | 5.71 | 4.253 | 3.903 | 4.366 | 3.594 | 3.534 | 3.708 | 2.815 | 3.506 | 3.034 | 2.472 | 1.997 | 1.426 | 1.565 | 1.603 | 1.399 | 1.452 | 1.524 |
| General & Administrative Expenses
| 0 | 0 | 0 | 19.523 | 0 | 0 | 0 | 15.808 | 0 | 0 | 0 | 13.809 | 0 | 0 | 0 | 10.813 | 10.813 | 0 | 0 | 10.024 | 8.621 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 4.8 | 0 | 0 | 0 | 6.1 | 0 | 0 | 0 | 5.1 | 0 | 0 | 0 | 3.147 | 0 | 0 | 0 | 0.6 | 0 | 0 | 0 |
| SG&A
| 25.411 | 25.314 | 24.304 | 24.323 | 23.985 | 23.463 | 22.736 | 21.908 | 19.717 | 21.235 | 20.245 | 18.909 | 16.686 | 17.62 | 15.604 | 13.96 | 10.813 | 11.112 | 10.189 | 10.024 | 8.621 | 8.357 | 7.779 |
| Other Expenses
| 0 | -0.035 | 0.415 | -0.357 | -0.262 | -0.162 | 0.108 | 0.201 | -0.432 | -0.165 | 0 | -0.383 | -0.267 | -0.096 | 0.161 | 0.23 | 2.631 | 0.568 | -0.147 | 0.096 | -0.34 | 0 | 0 |
| Operating Expenses
| 29.155 | 29.212 | 28.514 | 28.219 | 28.205 | 29.173 | 26.989 | 25.811 | 24.083 | 24.829 | 23.779 | 22.617 | 19.501 | 21.126 | 18.638 | 16.432 | 12.81 | 12.538 | 11.754 | 11.627 | 10.02 | 10.07 | 9.489 |
| Operating Income
| -14.129 | -13.905 | -14.536 | -13.919 | -15.176 | -16.439 | -16.4 | -14.627 | -13.931 | -14.411 | -15.668 | -12.366 | -9.762 | -12.097 | -12.027 | -9.354 | -5.348 | -11.526 | -6.104 | -4.29 | -3.613 | -4.856 | -4.968 |
| Operating Income Ratio
| -0.693 | -0.669 | -0.771 | -0.722 | -0.859 | -0.956 | -1.128 | -0.948 | -1.032 | -1.033 | -1.453 | -0.902 | -0.736 | -0.991 | -1.301 | -0.952 | -0.504 | -3.138 | -0.708 | -0.415 | -0.397 | -0.659 | -0.756 |
| Total Other Income Expenses Net
| 0.177 | 0.38 | 0.973 | 0.279 | 0.335 | 0.384 | 0.664 | 0.59 | -0.241 | -0.189 | -0.093 | -0.488 | -0.375 | -0.2 | 0.049 | 0.078 | 1.537 | -0.329 | -0.972 | -0.232 | -0.633 | -0.649 | -1.1 |
| Income Before Tax
| -13.952 | -15.242 | -13.563 | -13.64 | -14.841 | -16.055 | -15.736 | -14.037 | -14.172 | -14.6 | -15.761 | -12.854 | -10.137 | -12.297 | -11.978 | -9.276 | -3.811 | -11.855 | -7.076 | -4.522 | -4.246 | -5.505 | -5.786 |
| Income Before Tax Ratio
| -0.684 | -0.733 | -0.719 | -0.708 | -0.84 | -0.934 | -1.083 | -0.91 | -1.05 | -1.047 | -1.461 | -0.938 | -0.764 | -1.008 | -1.296 | -0.944 | -0.359 | -3.228 | -0.821 | -0.437 | -0.466 | -0.747 | -0.88 |
| Income Tax Expense
| 0.192 | 0.084 | 0.186 | 0.248 | 0.059 | 0.14 | 0.124 | 0.246 | -0.383 | 0.04 | 0.067 | 0.152 | 0.044 | 0.08 | 0.067 | 0.021 | 0.049 | 0.056 | 0.087 | 0.147 | 0.089 | 0.066 | 0.064 |
| Net Income
| -14.144 | -15.326 | -13.749 | -13.888 | -14.9 | -16.195 | -15.86 | -14.283 | -13.789 | -14.64 | -15.828 | -13.006 | -10.181 | -12.377 | -12.045 | -9.297 | -3.86 | -11.911 | -7.163 | -4.669 | -4.335 | -5.571 | -5.85 |
| Net Income Ratio
| -0.694 | -0.737 | -0.729 | -0.72 | -0.843 | -0.942 | -1.091 | -0.926 | -1.021 | -1.049 | -1.468 | -0.949 | -0.768 | -1.014 | -1.303 | -0.946 | -0.364 | -3.243 | -0.831 | -0.451 | -0.476 | -0.756 | -0.89 |
| EPS
| -0.36 | -0.39 | -0.36 | -0.36 | -0.39 | -0.43 | -0.42 | -0.38 | -0.37 | -0.4 | -0.43 | -0.35 | -0.28 | -0.34 | -0.34 | -0.27 | -0.11 | -0.39 | -0.35 | -0.23 | -0.21 | -3.26 | -3.42 |
| EPS Diluted
| -0.36 | -0.39 | -0.36 | -0.36 | -0.39 | -0.43 | -0.42 | -0.38 | -0.37 | -0.4 | -0.43 | -0.35 | -0.28 | -0.34 | -0.34 | -0.27 | -0.11 | -0.39 | -0.35 | -0.23 | -0.21 | -3.26 | -3.42 |
| EBITDA
| -12.685 | -13.951 | -12.157 | -12.348 | -13.533 | -14.112 | -14.074 | -12.766 | -13.503 | -14.001 | -15.195 | -11.761 | -9.724 | -12.097 | -12.027 | -8.964 | -2.586 | -10.826 | -6.061 | -3.96 | -3.691 | -4.777 | -5.191 |
| EBITDA Ratio
| -0.622 | -0.65 | -0.743 | -0.702 | -0.789 | -0.884 | -1.043 | -0.887 | -1.028 | -1.031 | -1.443 | -0.923 | -0.749 | -0.991 | -1.272 | -0.916 | -0.255 | -2.947 | -0.703 | -0.383 | -0.405 | -0.649 | -0.744 |